BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 26304115)

  • 1. The Alternative Splicing of Cytoplasmic Polyadenylation Element Binding Protein 2 Drives Anoikis Resistance and the Metastasis of Triple Negative Breast Cancer.
    Johnson RM; Vu NT; Griffin BP; Gentry AE; Archer KJ; Chalfant CE; Park MA
    J Biol Chem; 2015 Oct; 290(42):25717-27. PubMed ID: 26304115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serine/Arginine-Rich Splicing Factor 3 Modulates the Alternative Splicing of Cytoplasmic Polyadenylation Element Binding Protein 2.
    DeLigio JT; Stevens SC; Nazario-Muñoz GS; MacKnight HP; Doe KK; Chalfant CE; Park MA
    Mol Cancer Res; 2019 Sep; 17(9):1920-1930. PubMed ID: 31138601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Splice variants of cytosolic polyadenylation element-binding protein 2 (CPEB2) differentially regulate pathways linked to cancer metastasis.
    DeLigio JT; Lin G; Chalfant CE; Park MA
    J Biol Chem; 2017 Oct; 292(43):17909-17918. PubMed ID: 28904175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A TDO2-AhR signaling axis facilitates anoikis resistance and metastasis in triple-negative breast cancer.
    D'Amato NC; Rogers TJ; Gordon MA; Greene LI; Cochrane DR; Spoelstra NS; Nemkov TG; D'Alessandro A; Hansen KC; Richer JK
    Cancer Res; 2015 Nov; 75(21):4651-64. PubMed ID: 26363006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor suppressor role of cytoplasmic polyadenylation element binding protein 2 (CPEB2) in human mammary epithelial cells.
    Tordjman J; Majumder M; Amiri M; Hasan A; Hess D; Lala PK
    BMC Cancer; 2019 Jun; 19(1):561. PubMed ID: 31185986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer-Associated MORC2-Mutant M276I Regulates an hnRNPM-Mediated CD44 Splicing Switch to Promote Invasion and Metastasis in Triple-Negative Breast Cancer.
    Zhang FL; Cao JL; Xie HY; Sun R; Yang LF; Shao ZM; Li DQ
    Cancer Res; 2018 Oct; 78(20):5780-5792. PubMed ID: 30093560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PRKCQ promotes oncogenic growth and anoikis resistance of a subset of triple-negative breast cancer cells.
    Byerly J; Halstead-Nussloch G; Ito K; Katsyv I; Irie HY
    Breast Cancer Res; 2016 Sep; 18(1):95. PubMed ID: 27663795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin 17A promotes cell migration, enhances anoikis resistance, and creates a microenvironment suitable for triple negative breast cancer tumor metastasis.
    Tsai YF; Huang CC; Lin YS; Hsu CY; Huang CP; Liu CY; Chiu JH; Tseng LM
    Cancer Immunol Immunother; 2021 Aug; 70(8):2339-2351. PubMed ID: 33512556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An indispensable role of TAZ in anoikis resistance promoted by OTUB1 deubiquitinating enzyme in basal-like triple-negative breast cancer cells.
    Nakagawa H; Higurashi M; Ishikawa F; Mori K; Shibanuma M
    Biochem Biophys Res Commun; 2023 Mar; 649():1-9. PubMed ID: 36738577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy.
    Kren BT; Unger GM; Abedin MJ; Vogel RI; Henzler CM; Ahmed K; Trembley JH
    Breast Cancer Res; 2015; 17():19. PubMed ID: 25837326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA-binding protein MSI2 isoforms expression and regulation in progression of triple-negative breast cancer.
    Li M; Li AQ; Zhou SL; Lv H; Wei P; Yang WT
    J Exp Clin Cancer Res; 2020 May; 39(1):92. PubMed ID: 32448269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity-induced MBD2_v2 expression promotes tumor-initiating triple-negative breast cancer stem cells.
    Teslow EA; Mitrea C; Bao B; Mohammad RM; Polin LA; Dyson G; Purrington KS; Bollig-Fischer A
    Mol Oncol; 2019 Apr; 13(4):894-908. PubMed ID: 30636104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pygenic Acid A (PA) Sensitizes Metastatic Breast Cancer Cells to Anoikis and Inhibits Metastasis In Vivo.
    Lim GE; Sung JY; Yu S; Kim Y; Shim J; Kim HJ; Cho ML; Lee JS; Kim YN
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33182770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The matricellular protein CYR61 promotes breast cancer lung metastasis by facilitating tumor cell extravasation and suppressing anoikis.
    Huang YT; Lan Q; Lorusso G; Duffey N; Rüegg C
    Oncotarget; 2017 Feb; 8(6):9200-9215. PubMed ID: 27911269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curcumol Suppresses Triple-negative Breast Cancer Metastasis by Attenuating Anoikis Resistance
    Li CL; Huang CW; Ko CJ; Fang SY; Ou-Yang FU; Pan MR; Luo CW; Hou MF
    Anticancer Res; 2020 Oct; 40(10):5529-5538. PubMed ID: 32988876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MCPIP1-mediated NFIC alternative splicing inhibits proliferation of triple-negative breast cancer via cyclin D1-Rb-E2F1 axis.
    Chen F; Wang Q; Yu X; Yang N; Wang Y; Zeng Y; Zheng Z; Zhou F; Zhou Y
    Cell Death Dis; 2021 Apr; 12(4):370. PubMed ID: 33824311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRA2A Promoted Paclitaxel Resistance and Tumor Progression in Triple-Negative Breast Cancers via Regulating Alternative Splicing.
    Liu T; Sun H; Zhu D; Dong X; Liu F; Liang X; Chen C; Shao B; Wang M; Wang Y; Sun B
    Mol Cancer Ther; 2017 Jul; 16(7):1377-1388. PubMed ID: 28416606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Positive Feedback Loop Between TGFβ and Androgen Receptor Supports Triple-negative Breast Cancer Anoikis Resistance.
    Rosas E; Roberts JT; O'Neill KI; Christenson JL; Williams MM; Hanamura T; Spoelstra NS; Vahrenkamp JM; Gertz J; Richer JK
    Endocrinology; 2021 Feb; 162(2):. PubMed ID: 33294922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARNP, a participant in mRNA splicing and export, negatively regulates E-cadherin expression via interaction with pinin.
    Kang GJ; Park MK; Byun HJ; Kim HJ; Kim EJ; Yu L; Kim B; Shim JG; Lee H; Lee CH
    J Cell Physiol; 2020 Feb; 235(2):1543-1555. PubMed ID: 31313837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA LINC-PINT attenuates paclitaxel resistance in triple-negative breast cancer cells via targeting the RNA-binding protein NONO.
    Chen J; Zhu M; Zou L; Xia J; Huang J; Deng Q; Xu R
    Acta Biochim Biophys Sin (Shanghai); 2020 Aug; 52(8):801-809. PubMed ID: 32632453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.